Ms Carolyn Sarah Barnes, OTRL | |
13400 E Shea Blvd, Scottsdale, AZ 85259-5452 | |
(904) 953-2150 | |
Not Available |
Full Name | Ms Carolyn Sarah Barnes |
---|---|
Gender | Female |
Speciality | Occupational Therapy |
Experience | 24 Years |
Location | 13400 E Shea Blvd, Scottsdale, Arizona |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1447203955 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 2678 (Arizona) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mayo Clinic - Arizona | 7012829930 | 1395 |
News Archive
Most Latinx people who are LGBTQI+ reported being reluctant to share their gender identity and/or sexual orientation with a health care provider, and a majority have never received cancer information tailored for their community, according to City of Hope-led survey results that will be presented at an American Association for Cancer Research (AACR) meeting held from Sept. 20-23.
Illumina, Inc. today unveiled its new HumanOmniExpress+ Custom BeadChip (OmniExpress+), an enhancement to the recently announced OmniExpress BeadChip that allows for the addition of up to 200,000 custom variants for a total of >900k variants per sample. OmniExpress+ leverages the proven iSelect custom genotyping infrastructure to provide researchers with unlimited flexibility in adding custom content for disease or pathway-specific markers, rare variants from the 1,000 Genomes Project, or panels for fine-mapping onto the industry's most optimal set of SNPs.
Professor and researcher of the Faculty of Nursing and Podiatry of the UV, Yasmín Ezzatvar, together with researchers from other centers, concludes that the racial or ethnic group of patients with type 1 and 2 diabetes mellitus influences the prognosis of the disease, due to differences in mortality, risk of kidney disease or risk of cardiovascular disease.
Adimab, Inc., a technology leader in the discovery of fully human antibodies, today announced the initiation of three new independent research collaborations with Eli Lilly, Genentech, and Human Genome Sciences. Over the past 18 months Adimab has established collaborations with several leading Pharmaceutical companies including: Merck, Roche, Novartis, Pfizer, and now Eli Lilly, Genentech, and Human Genome Sciences.
› Verified 2 days ago
Provider Name | Mayo Clinic Arizona |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1558332494 PECOS PAC ID: 7012829930 Enrollment ID: O20031105000782 |
News Archive
Most Latinx people who are LGBTQI+ reported being reluctant to share their gender identity and/or sexual orientation with a health care provider, and a majority have never received cancer information tailored for their community, according to City of Hope-led survey results that will be presented at an American Association for Cancer Research (AACR) meeting held from Sept. 20-23.
Illumina, Inc. today unveiled its new HumanOmniExpress+ Custom BeadChip (OmniExpress+), an enhancement to the recently announced OmniExpress BeadChip that allows for the addition of up to 200,000 custom variants for a total of >900k variants per sample. OmniExpress+ leverages the proven iSelect custom genotyping infrastructure to provide researchers with unlimited flexibility in adding custom content for disease or pathway-specific markers, rare variants from the 1,000 Genomes Project, or panels for fine-mapping onto the industry's most optimal set of SNPs.
Professor and researcher of the Faculty of Nursing and Podiatry of the UV, Yasmín Ezzatvar, together with researchers from other centers, concludes that the racial or ethnic group of patients with type 1 and 2 diabetes mellitus influences the prognosis of the disease, due to differences in mortality, risk of kidney disease or risk of cardiovascular disease.
Adimab, Inc., a technology leader in the discovery of fully human antibodies, today announced the initiation of three new independent research collaborations with Eli Lilly, Genentech, and Human Genome Sciences. Over the past 18 months Adimab has established collaborations with several leading Pharmaceutical companies including: Merck, Roche, Novartis, Pfizer, and now Eli Lilly, Genentech, and Human Genome Sciences.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Ms Carolyn Sarah Barnes, OTRL 13400 E Shea Blvd, Scottsdale, AZ 85259-5452 Ph: (480) 301-8000 | Ms Carolyn Sarah Barnes, OTRL 13400 E Shea Blvd, Scottsdale, AZ 85259-5452 Ph: (904) 953-2150 |
News Archive
Most Latinx people who are LGBTQI+ reported being reluctant to share their gender identity and/or sexual orientation with a health care provider, and a majority have never received cancer information tailored for their community, according to City of Hope-led survey results that will be presented at an American Association for Cancer Research (AACR) meeting held from Sept. 20-23.
Illumina, Inc. today unveiled its new HumanOmniExpress+ Custom BeadChip (OmniExpress+), an enhancement to the recently announced OmniExpress BeadChip that allows for the addition of up to 200,000 custom variants for a total of >900k variants per sample. OmniExpress+ leverages the proven iSelect custom genotyping infrastructure to provide researchers with unlimited flexibility in adding custom content for disease or pathway-specific markers, rare variants from the 1,000 Genomes Project, or panels for fine-mapping onto the industry's most optimal set of SNPs.
Professor and researcher of the Faculty of Nursing and Podiatry of the UV, Yasmín Ezzatvar, together with researchers from other centers, concludes that the racial or ethnic group of patients with type 1 and 2 diabetes mellitus influences the prognosis of the disease, due to differences in mortality, risk of kidney disease or risk of cardiovascular disease.
Adimab, Inc., a technology leader in the discovery of fully human antibodies, today announced the initiation of three new independent research collaborations with Eli Lilly, Genentech, and Human Genome Sciences. Over the past 18 months Adimab has established collaborations with several leading Pharmaceutical companies including: Merck, Roche, Novartis, Pfizer, and now Eli Lilly, Genentech, and Human Genome Sciences.
› Verified 2 days ago
Ms. Attria Batoon Honda, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 12000 N 90th T., Scottsdale, AZ 85260 Phone: 480-451-2033 | |
Jennifer Klaine, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1475 N Granite Reef Rd, Scottsdale, AZ 85257 Phone: 480-990-1904 | |
Jared Stuck, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 16413 N 91st St Bldg C145, Scottsdale, AZ 85260 Phone: 480-447-3262 Fax: 480-630-2066 | |
Emily Ludwig, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 13802 N Scottsdale Rd Ste 163, Scottsdale, AZ 85254 Phone: 480-401-1848 | |
Siyu Yi, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 7025 N Scottsdale Rd Ste 200, Scottsdale, AZ 85253 Phone: 602-385-8733 | |
Ms. Connie Sue Williams, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8115 E Indian Bend Rd, Ste 123, Scottsdale, AZ 85250 Phone: 480-951-6451 | |
Tonya Lee Soules, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8429 E Via De Jardin, Scottsdale, AZ 85258 Phone: 480-664-1266 |